121845-47-4 Usage
Uses
Used in Pharmaceutical and Chemical Industries:
3-TERT-BUTYLPYRIDO[3,4-E][1,2,4]TRIAZINE is used as a key intermediate in the synthesis of various pharmaceutical compounds for its potential therapeutic effects, particularly in the development of anticancer drugs. Its unique chemical structure allows it to be a versatile building block in the creation of novel molecules with potential medicinal properties.
Used in Drug Discovery and Development:
3-TERT-BUTYLPYRIDO[3,4-E][1,2,4]TRIAZINE is utilized as a research compound for exploring its antiproliferative and anticancer activities. It serves as a basis for investigating new treatment options for cancer, with the aim of identifying more effective and targeted therapies.
Used in Cancer Treatment:
3-TERT-BUTYLPYRIDO[3,4-E][1,2,4]TRIAZINE is employed as a potential anticancer agent, given its demonstrated ability to inhibit the proliferation of cancer cells. It is under investigation for its role in treating various types of cancer, with the goal of contributing to a broader arsenal of cancer-fighting medications.
Check Digit Verification of cas no
The CAS Registry Mumber 121845-47-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,1,8,4 and 5 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 121845-47:
(8*1)+(7*2)+(6*1)+(5*8)+(4*4)+(3*5)+(2*4)+(1*7)=114
114 % 10 = 4
So 121845-47-4 is a valid CAS Registry Number.
InChI:InChI=1/C10H12N4/c1-10(2,3)9-12-8-6-11-5-4-7(8)13-14-9/h4-6H,1-3H3
121845-47-4Relevant academic research and scientific papers
Pyrido[3,4-e]-1,2,4-triazines and related heterocycles as potential antifungal agents
Reich,Fabio,Lee,Kuck,Testa
, p. 2474 - 2485 (2007/10/02)
The preparation and biological activities of a series of pyrido[3,4-e]-1,2,4-triazines, 1,2,4-triazino[5,6-c]quinolines, and related fused triazines are described. Methyl, amino, and acylamino substituents were placed in the pyridyl ring of the former system. Other structural modifications included various alkyl, cycloalkyl, substituted phenyl, and heterocyclic groups in the 3-position of these ring systems. In agar dilution assays, actives in this series inhibited strains of Candida, Aspergillus, Mucor, and Trychophyton species at MIC's of ≤ 16 μg/mL.
